Диссертация (1145685), страница 22
Текст из файла (страница 22)
Martin, R. Beyaert // Immunity – 2015. – Т. 42 – № 6 – 991–1004 p.5. Aida Y. Removal of endotoxin from protein solutions by phase separation using Triton X-114 / Y.Aida, M. J. Pabst // J. Immunol. Methods – 1990. – Т. 132 – № 2 – 191–195 p.6. Andre R. Regulation of expression of the novel IL-1 receptor family members in the mouse brain /R. Andre, D. Lerouet, I. Kimber, E. Pinteaux, N. J.
Rothwell // J. Neurochem. – 2005. – Т. 95 – № 2 –324–330 p.7. Anspach F.B. Removal of endotoxins by affinity sorbents / F. B. Anspach, O. Hilbeck // J.Chromatogr. A – 1995. – Т. 711 – № 1 – 81–92 p.8. Aoyagi T. IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenzapneumonia / T. Aoyagi, M. W. Newstead, X. Zeng, S. L. Kunkel, M. Kaku, T. J.
Standiford // MucosalImmunol. – 2017. – Т. 10 – № 4 – 1043–1055 p.9. Asseldonk E.J.P. van The effect of the interleukin-1 cytokine family members IL-1F6 and IL-1F8on adipocyte differentiation / E. J. P. van Asseldonk, R. Stienstra, T. B. Koenen, L. J. H. van Tits, L.127A. B. Joosten, C. J. Tack, M.
G. Netea // Obes. Silver Spring Md – 2010. – Т. 18 – № 11 – 2234–2236p.10. Bal E. Mutation in IL36RN impairs the processing and regulatory function of the interleukin-36receptor antagonist and is associated with DITRA syndrome / E. Bal, A. C. Lim, M. Shen, J.Douangpanya, M. Madrange, R.
Gazah, M. Tauber, W. Beghdadi, J. L. Casanova, E. Bourrat, H.Bachelez, J. E. Towne, A. Smahi // Exp. Dermatol. – 2017.11. Barton J.L. A tissue specific IL-1 receptor antagonist homolog from the IL-1 cluster lacks IL-1, IL1ra, IL-18 and IL-18 antagonist activities / J. L. Barton, R. Herbst, D. Bosisio, L.
Higgins, M. J.Nicklin // Eur. J. Immunol. – 2000. – Т. 30 – № 11 – 3299–3308 p.12. Ben-Bassat A. Processing of the initiation methionine from proteins: properties of the Escherichiacoli methionine aminopeptidase and its gene structure / A. Ben-Bassat, K. Bauer, S. Y. Chang, K.Myambo, A. Boosman, S.
Chang // J. Bacteriol. – 1987. – Т. 169 – № 2 – 751–757 p.13. Berglöf E. IL-1Rrp2 expression and IL-1F9 (IL-1H1) actions in brain cells / E. Berglöf, R. Andre,B. R. Renshaw, S. M. Allan, C. B. Lawrence, N. J. Rothwell, E. Pinteaux // J. Neuroimmunol. – 2003.– Т. 139 – № 1–2 – 36–43 p.14. Bhosale M. Characterization of two M17 family members in Escherichia coli, Peptidase A andPeptidase B / M. Bhosale, S. Pande, A. Kumar, S. Kairamkonda, D. Nandi // Biochem.
Biophys. Res.Commun. – 2010. – Т. 395 – № 1 – 76–81 p.15. Blumberg H. Opposing activities of two novel members of the IL-1 ligand family regulate skininflammation / H. Blumberg, H. Dinh, E. S. Trueblood, J. Pretorius, D. Kugler, N. Weng, S.
T.Kanaly, J. E. Towne, C. R. Willis, M. K. Kuechle, J. E. Sims, J. J. Peschon // J. Exp. Med. – 2007. – Т.204 – № 11 – 2603–2614 p.16. Boehncke W.-H. Etiology and Pathogenesis of Psoriasis / W.-H. Boehncke // Rheum. Dis. Clin.North Am. – 2015. – Т. 41 – № 4 – 665–675 p.17. Boehncke W.-H. Psoriasis / W.-H. Boehncke, M. P. Schön // Lancet Lond. Engl. – 2015.
– Т. 386– № 9997 – 983–994 p.12818. Bozoyan L. Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no rolein experimental autoimmune encephalomyelitis / L. Bozoyan, A. Dumas, A. Patenaude, L. Vallières //J. Neuroinflammation – 2015. – Т. 12 – 173 p.19. Brau-Javier C.N. Chronic cutaneous pustulosis due to a 175-kb deletion on chromosome 2q13:excellent response to anakinra / C.
N. Brau-Javier, J. Gonzales-Chavez, J. R. Toro // Arch. Dermatol. –2012. – Т. 148 – № 3 – 301–304 p.20. Bruschi M. Post-translational modified proteins are biomarkers of autoimmune-processes: NETosisand the inflammatory-autoimmunity connection / M. Bruschi, A. Petretto, R. Bertelli, M. Galetti, A.Bonanni, F. Pratesi, P. Migliorini, G. Candiano, A. Vaglio, G. M. Ghiggeri // Clin. Chim. Acta Int.
J.Clin. Chem. – 2017. – Т. 464 – 12–16 p.21. Busfield S.J. Identification and gene organization of three novel members of the IL-1 family onhuman chromosome 2 / S. J. Busfield, C. A. Comrack, G. Yu, T. W. Chickering, J. S. Smutko, H.Zhou, K. R. Leiby, L. M.
Holmgren, D. P. Gearing, Y. Pan // Genomics – 2000. – Т. 66 – № 2 – 213–216 p.22. Carrier Y. Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo:implications in psoriasis pathogenesis / Y. Carrier, H.-L. Ma, H. E. Ramon, L.
Napierata, C. Small, M.O’Toole, D. A. Young, L. A. Fouser, C. Nickerson-Nutter, M. Collins, K. Dunussi-Joannopoulos, Q.G. Medley // J. Invest. Dermatol. – 2011. – Т. 131 – № 12 – 2428–2437 p.23. Cassell S. Psoriatic arthritis: pathogenesis and novel immunomodulatory approaches to treatment /S. Cassell, A. Kavanaugh // J. Immune Based Ther. Vaccines – 2005.
– Т. 3 – 6 p.24. Cavallaro A.S. Endotoxin-free purification for the isolation of bovine viral diarrhoea virus E2protein from insoluble inclusion body aggregates / A. S. Cavallaro, D. Mahony, M. Commins, T. J.Mahony, N. Mitter // Microb. Cell Factories – 2011. – Т. 10 – 57 p.25. Chen H. Alterations of plasma inflammatory biomarkers in the healthy and chronic obstructivepulmonary disease patients with or without acute exacerbation / H. Chen, Y.
Wang, C. Bai, X. Wang //J. Proteomics – 2012. – Т. 75 – № 10 – 2835–2843 p.12926. Chen R.H. Factors affecting endotoxin removal from recombinant therapeutic proteins by anionexchange chromatography / R. H. Chen, C.-J. Huang, B. S. Newton, G. Ritter, L. J. Old, C. A. Batt //Protein Expr. Purif. – 2009. – Т. 64 – № 1 – 76–81 p.27.
Chustz R.T. Regulation and function of the IL-1 family cytokine IL-1F9 in human bronchialepithelial cells / R. T. Chustz, D. R. Nagarkar, J. A. Poposki, S. Favoreto, P. C. Avila, R. P. Schleimer,A. Kato // Am. J. Respir. Cell Mol. Biol. – 2011. – Т. 45 – № 1 – 145–153 p.28. Clancy D.M. Neutrophil extracellular traps can serve as platforms for processing and activation ofIL-1 family cytokines / D. M. Clancy, C. M.
Henry, G. P. Sullivan, S. J. Martin // FEBS J. – 2017. – Т.284 – № 11 – 1712–1725 p.29. Cohen P. The TLR and IL-1 signalling network at a glance / P. Cohen // J. Cell Sci. – 2014. – Т.127 – № Pt 11 – 2383–2390 p.30. Costa L. Efficacy of tocilizumab in a patient with refractory psoriatic arthritis / L. Costa, F. Caso,L. Cantarini, A. Del Puente, R. Scarpa, M. Atteno // Clin. Rheumatol.
– 2014. – Т. 33 – № 9 – 1355–1357 p.31. Dalbøge H. In vivo processing of N-terminal methionine in E. coli / H. Dalbøge, S. Bayne, J.Pedersen // FEBS Lett. – 1990. – Т. 266 – № 1–2 – 1–3 p.32. D’Erme A.M. IL-36γ (IL-1F9) Is a Biomarker for Psoriasis Skin Lesions / A. M. D’Erme, D.Wilsmann-Theis, J. Wagenpfeil, M. Hölzel, S. Ferring-Schmitt, S. Sternberg, M. Wittmann, B.
Peters,A. Bosio, T. Bieber, J. Wenzel // J. Invest. Dermatol. – 2015. – Т. 135 – № 4 – 1025–1032 p.33. Dinarello C. IL-1 family nomenclature / C. Dinarello, W. Arend, J. Sims, D. Smith, H. Blumberg,L. O’Neill, R. Goldbach-Mansky, T. Pizarro, H. Hoffman, P. Bufler, M. Nold, P. Ghezzi, A.Mantovani, C. Garlanda, D. Boraschi, A.
Rubartelli, M. Netea, J. van der Meer, L. Joosten, T.Mandrup-Poulsen, M. Donath, E. Lewis, J. Pfeilschifter, M. Martin, M. Kracht, H. Muehl, D. Novick,M. Lukic, B. Conti, A. Solinger, P. Kelk, K. Peyman, F. van de Veerdonk, C. Gabel // Nat. Immunol. –2010. – Т. 11 – № 11 – 973 p.34. Dunn E. Annotating genes with potential roles in the immune system: six new members of the IL-1family / E.
Dunn, J. E. Sims, M. J. Nicklin, L. A. O’Neill // Trends Immunol. – 2001. – Т. 22 – № 10 –533–536 p.13035. Dunn E.F. High-resolution structure of murine interleukin 1 homologue IL-1F5 reveals uniqueloop conformations for receptor binding specificity / E. F. Dunn, N. J. Gay, A. F. Bristow, D. P.Gearing, L. A. J. O’Neill, X. Y. Pei // Biochemistry (Mosc.) – 2003. – Т. 42 – № 37 – 10938–10944 p.36. Farahnik B. Topical Botanical Agents for the Treatment of Psoriasis: A Systematic Review / B.Farahnik, D. Sharma, J. Alban, R. K.
Sivamani // Am. J. Clin. Dermatol. – 2017. – Т. 18 – № 4 – 451–468 p.37. Farooq M. Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustularpsoriasis / M. Farooq, H. Nakai, A. Fujimoto, H. Fujikawa, A. Matsuyama, N. Kariya, A. Aizawa, H.Fujiwara, M. Ito, Y. Shimomura // Hum.
Mutat. – 2013. – Т. 34 – № 1 – 176–183 p.38. Finch A. Analysis of mitogen-activated protein kinase pathways used by interleukin 1 in tissues invivo: activation of hepatic c-Jun N-terminal kinases 1 and 2, and mitogen-activated protein kinasekinases 4 and 7 / A. Finch, W. Davis, W. G. Carter, J. Saklatvala // Biochem. J. – 2001. – Т. 353 – №Pt 2 – 275–281 p.39. Fits L. van der Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL23/IL-17 axis / L. van der Fits, S. Mourits, J. S. A. Voerman, M. Kant, L. Boon, J.
D. Laman, F.Cornelissen, A.-M. Mus, E. Florencia, E. P. Prens, E. Lubberts // J. Immunol. Baltim. Md 1950 –2009. – Т. 182 – № 9 – 5836–5845 p.40. Franken K.L. Purification of his-tagged proteins by immobilized chelate affinity chromatography:the benefits from the use of organic solvent / K.
L. Franken, H. S. Hiemstra, K. E. van Meijgaarden, Y.Subronto, J. den Hartigh, T. H. Ottenhoff, J. W. Drijfhout // Protein Expr. Purif. – 2000. – Т. 18 – № 1– 95–99 p.41. Frottin F. The proteomics of N-terminal methionine cleavage / F. Frottin, A. Martinez, P. Peynot,S. Mitra, R. C. Holz, C. Giglione, T. Meinnel // Mol. Cell. Proteomics MCP – 2006. – Т. 5 – № 12 –2336–2349 p.42.
Gabay C. Regulation and function of interleukin-36 cytokines in homeostasis and pathologicalconditions / C. Gabay, J. E. Towne // J. Leukoc. Biol. – 2015. – Т. 97 – № 4 – 645–652 p.43. Gagnon P. Monoclonal antibody purification with hydroxyapatite / P. Gagnon // New Biotechnol. –2009. – Т. 25 – № 5 – 287–293 p.13144. Ganesan R. Generation and functional characterization of anti-human and anti-mouse IL-36Rantagonist monoclonal antibodies / R. Ganesan, E.
L. Raymond, D. Mennerich, J. R. Woska, G.Caviness, C. Grimaldi, J. Ahlberg, R. Perez, S. Roberts, D. Yang, K. Jerath, K. Truncali, L. Frego, E.Sepulveda, P. Gupta, S.-E. Brown, M. D. Howell, K. A. Canada, R. Kroe-Barrett, J. S. Fine, S. Singh,M. L. Mbow // mAbs – 2017.
– 0 p.45. Garber C. Systemic Treatment of Recalcitrant Pediatric Psoriasis: A Case Series and LiteratureReview / C. Garber, M. Creighton-Smith, E. P. Sorensen, N. Dumont, A. B. Gottlieb // J. DrugsDermatol. JDD – 2015. – Т. 14 – № 8 – 881–886 p.46. Garlanda C. Decoys and Regulatory «Receptors» of the IL-1/Toll-Like Receptor Superfamily / C.Garlanda, F. Riva, E. Bonavita, S. Gentile, A. Mantovani // Front. Immunol. – 2013. – Т. 4 – 180 p.47. Gasteiger E. Protein Identification and Analysis Tools on the ExPASy Server / под ред.
J. Walker.Humana Press, 2005. – 571–607 p.48. Gresnigt M.S. Biology of IL-36 cytokines and their role in disease / M. S. Gresnigt, F. L. van deVeerdonk // Semin. Immunol. – 2013. – Т. 25 – № 6 – 458–465 p.49. Griffiths C.E.M. Pathogenesis and clinical features of psoriasis / C. E. M. Griffiths, J. N. W. N.Barker // Lancet Lond. Engl. – 2007. – Т. 370 – № 9583 – 263–271 p.50. Grote A. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host /A. Grote, K. Hiller, M. Scheer, R. Münch, B. Nörtemann, D. C. Hempel, D.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
